Recognising that India plays a crucial role in supplying the world with vaccines, IMAPAC aims to bring together, for the fourth consecutive year, players from the Indian and international vaccine industry at the fourth Annual Vaccine World Summit India 2014. It is being held from March 4-6, 2014 in Hyderabad.
The Indian vaccine industry is expected to grow at 10-13 per cent over the next 10 years. India is the major supplier of basic Expanded Programme on Immunisation vaccine to the United Nations Children’s Fund (UNICEF). Dr Suresh Jadhav, Executive Director, Serum Institute of India, showed the importance India as a global vaccine supplier, when he said, “Around 75-to-80 per cent of vaccines developed and procured by UN agencies are from the developing world and almost 80 per cent of these are from India”.
The Indian vaccine manufacturers are more involved in the global market than ever. More international collaborations can be seen and the Indian vaccine players are also stepping up their game by acquiring foreign partners around the world. IMAPAC intends to provide a platform to connect key stakeholders, to facilitate learning, as well as sharing of experiences and knowledge through the conference.
Reportedly, this conference features a distinguished panel more than 35 speakers and advisers; each of them playing important roles in their organisations.These key opinion leaders will share their thoughts and discuss key concerns revolving regulations, new technologies, partnerships and clinical trials.
The 4th Annual Vaccine World Summit is supported by international organisations such as Wellcome Trust, Bio Deutschland, the Embassy of Netherlands and more.
EP News Bureau – Mumbai